Aethon Therapeutics

0 followers


Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer-associated mutations.

Employees

1-10

Links

Org chart

Raj Chopra

Collapse
Paul Da Silva Jardine
Chief Scientific Officer
Lauren Stopfer
Head of Proteomics

Teams

This company has no teams yet